Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
MedTech
Thermo Fisher debuts protein panel for neurodegeneration R&D
The addition of the multiplex immunoassay panel to the company’s Target 48 proteomics line follows last year’s $3.1 billion acquisition of Olink.
Conor Hale
Sep 16, 2025 12:00pm
AC Immune cuts workforce by 30%, trims pipeline to preserve cash
Sep 4, 2025 10:27am
Novartis aims at alpha-synuclein again with $2.2B Arrowhead deal
Sep 2, 2025 9:55am
InBrain unveils positive interim findings from BCI tech study
Jul 30, 2025 11:00am
Elevidys fallout hasn't dented Roche's hopes for gene therapies
Jul 25, 2025 8:30am
FDA clears Fasikl AI stimulation wristwatch for essential tremor
Jul 3, 2025 9:15am
